Clinical Trial Update: Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update describes a nonmyeloablative hematopoietic stem cell transplant approach for sickle cell disease patients with anti-donor red…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Children's National Research Institute | Conditions: Sickle Cell Disease | Phase 2 | Status: RECRUITING